American Cannabis Company, Inc.: management transactions · United States · SEC (Form 4)

About American Cannabis Company, Inc.

American Cannabis Company, Inc. (ticker: AMMJ) is a U.S.-based micro-cap company focused on services and equipment for the regulated cannabis industry. SEC filings indicate the company is associated with the U.S. OTC market rather than being listed on NYSE/NASDAQ, and its principal executive office has been reported in Colorado Springs, Colorado, underscoring its operational base in the United States. ([sec.gov](https://www.sec.gov/Archives/edgar/data/945617/000190359626000195/ammj_8k.htm?utm_source=openai)) From a historical perspective, the company was incorporated in Delaware on September 24, 2001 under the name Naturewell, Inc. It later underwent a strategic transformation, including a 2014 merger and rebranding into American Cannabis Company, Inc., which marked its shift away from its earlier business model and into the cannabis sector. This corporate evolution is important for investors because it shows that AMMJ is not a legacy consumer brand, but a reorganized platform built around regulated cannabis opportunities. ([sec.gov](https://www.sec.gov/Archives/edgar/data/945617/000072174815000244/ammj10k033115.htm?utm_source=openai)) The company’s business model is best described as an end-to-end cannabis industry solutions provider. According to SEC disclosures, it offers advisory and consulting services, designs industry-specific facilities and operational solutions, and markets proprietary products such as Satchel™, SoHum Living Soils™, Cultivation Cube™, and the High Density Cultivation System™. It also sells third-party cannabis-related products and has, at times, operated Colorado dispensary and cultivation assets under the Naturaleaf brand, giving the company a mix of service, product, and direct operating exposure. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0000945617/000172186817000093/ammj10qa112117.htm?utm_source=openai)) In competitive terms, American Cannabis Company occupies a niche position rather than competing as a scaled cannabis cultivator or multi-state operator. Its value proposition is rooted in regulatory expertise, facility design, consulting, and specialized equipment/services for operators in legal cannabis markets. That niche can be attractive in a fragmented industry where licensing, compliance, and operating know-how matter, but it also means AMMJ is highly exposed to the spending capacity of cannabis operators, the broader capital markets cycle, and ongoing regulatory uncertainty around cannabis in the United States. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0000945617/000172186817000093/ammj10qa112117.htm?utm_source=openai)) Recent corporate developments are notable. On May 8, 2026, Joe Cleghorn stepped down as CEO, and James Woodend was appointed Chief Executive Officer and Chairman of the Board, effective immediately. For investors, leadership changes of this type can be a meaningful signal of strategic refocusing, operational restructuring, or capital-allocation priorities. Overall, AMMJ remains a speculative small-cap cannabis-related name for investors in French-speaking markets to monitor, especially if regulatory normalization or stronger sector activity improves demand for compliance-driven consulting and infrastructure solutions in the United States. ([sec.gov](https://www.sec.gov/Archives/edgar/data/945617/000190359626000195/ammj_8k.htm?utm_source=openai))